相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。LRRK2 links genetic and sporadic Parkinson's disease
Jillian H. Kluss et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
The role of monogenic genes in idiopathic Parkinson's disease
Xylena Reed et al.
NEUROBIOLOGY OF DISEASE (2019)
Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo
Elena Kozina et al.
BRAIN (2018)
The impact of murine LRRK2 G2019S transgene overexpression on acute responses to inflammatory challenge
Darcy Litteljohn et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Neural pathways involved in infection-induced inflammation: recent insights and clinical implications
Marion Griton et al.
CLINICAL AUTONOMIC RESEARCH (2018)
Involvement of Neuroinflammation in the Pathogenesis of Monocrotaline-Induced Pulmonary Hypertension
Ravindra K. Sharma et al.
HYPERTENSION (2018)
HFE Genotype Restricts the Response to Paraquat in a Mouse Model of Neurotoxicity
Anne M. Nixon et al.
JOURNAL OF NEUROCHEMISTRY (2018)
LRRK2 G2019S Induces Anxiety/Depression-like Behavior before the Onset of Motor Dysfunction with 5-HT1A Receptor Upregulation in Mice
Juhee Lim et al.
JOURNAL OF NEUROSCIENCE (2018)
Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: involvement of oxidative stress and neuroinflammation
Ismail O. Ishola et al.
METABOLIC BRAIN DISEASE (2018)
Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease Models
Pablo Garrido-Gil et al.
MOLECULAR NEUROBIOLOGY (2018)
Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson's disease
Kwang Soo Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
LRRK2 kinase in Parkinson's disease
Dario R. Alessi et al.
SCIENCE (2018)
Vitamin D treatment abrogates the inflammatory response in paraquat-induced lung fibrosis
Adriana Schapochnik et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
LRRK2 Kinase Activity Induces Mitochondrial Fission in Microglia via Drp1 and Modulates Neuroinflammation
Dong Hwan Ho et al.
EXPERIMENTAL NEUROBIOLOGY (2018)
Bidirectional Microglia-Neuron Communication in Health and Disease
Zsuzsanna Szepesi et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
A Nigro-Vagal Pathway Controls Gastric Motility and Is Affected in a Rat Model of Parkinsonism
Laura Anselmi et al.
GASTROENTEROLOGY (2017)
Chloroquine attenuates paraquat-induced lung injury in mice by altering inflammation, oxidative stress and fibrosis
Haitao Shen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Penetrance Estimate of LRRK2 p.G2019S Mutation in Individuals of Non-Ashkenazi Jewish Ancestry
Annie J. Lee et al.
MOVEMENT DISORDERS (2017)
Non-motor features of Parkinson disease
Anthony H. V. Schapira et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Age and Chronicity of Administration Dramatically Influenced the Impact of Low Dose Paraquat Exposure on Behavior and Hypothalamic-Pituitary-Adrenal Activity
Chris A. Rudyk et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Gamma-Secretase Inhibitors Attenuate Neurotrauma and Neurogenic Acute Lung Injury in Rats by Rescuing the Accumulation of Hypertrophic Microglia
Hung-Jung Lin et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Cromolyn Sodium Attenuates Paraquat-Induced Lung Injury by Modulation of Proinflammatory Cytokines
Amir Larki Harchegani et al.
DRUG RESEARCH (2017)
LRRK2 levels in immune cells are increased in Parkinson'sdisease
D. A. Cook et al.
NPJ PARKINSONS DISEASE (2017)
LRRK2 modulates microglial activity through regulation of chemokine (C-X3-C) receptor 1-mediated signalling pathways
Bo Ma et al.
HUMAN MOLECULAR GENETICS (2016)
LRRK2 G2019S transgenic mice display increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-mediated neurotoxicity
Senthilkumar S. Karuppagounder et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2016)
G2019S-LRRK2 Expression Augments α-Synuclein Sequestration into Inclusions in Neurons
Laura A. Volpicelli-Daley et al.
JOURNAL OF NEUROSCIENCE (2016)
Association between Parkinson's Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis
Charles B. Breckenridge et al.
PLOS ONE (2016)
The blood-brain barrier in neuroimmunology: Tales of separation and assimilation
W. A. Banks
BRAIN BEHAVIOR AND IMMUNITY (2015)
LRRK2 mutations and neurotoxicant susceptibility
Jang-Won Lee et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
The G2019S LRRK2 mutation increases myeloid cell chemotactic responses and enhances LRRK2 binding to actin-regulatory proteins
Mark S. Moehle et al.
HUMAN MOLECULAR GENETICS (2015)
Time-dependent effects of CX3CR1 in a mouse model of mild traumatic brain injury
Heidi Y. Febinger et al.
JOURNAL OF NEUROINFLAMMATION (2015)
The Parkinson's Disease-Associated Mutation LRRK2-G2019S Impairs Synaptic Plasticity in Mouse Hippocampus
Eric S. Sweet et al.
JOURNAL OF NEUROSCIENCE (2015)
Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats
Jang-Won Lee et al.
NEUROBIOLOGY OF AGING (2015)
Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice
M. Yue et al.
NEUROBIOLOGY OF DISEASE (2015)
Increased toll-like receptor 9 expression is associated with the severity of paraquat-induced lung injury in mice
J. Qian et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2015)
No Dopamine Cell Loss or Changes in Cytoskeleton Function in Transgenic Mice Expressing Physiological Levels of Wild Type or G2019S Mutant LRRK2 and in Human Fibroblasts
Marta Garcia-Miralles et al.
PLOS ONE (2015)
Paraquat and psychological stressor interactions as pertains to Parkinsonian co-morbidity
Chris Rudyk et al.
NEUROBIOLOGY OF STRESS (2015)
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
Staffan Holmqvist et al.
ACTA NEUROPATHOLOGICA (2014)
LRRK2 and neuroinflammation: partners in crime in Parkinson's disease?
Isabella Russo et al.
JOURNAL OF NEUROINFLAMMATION (2014)
(G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse
Jun-Shiao Chou et al.
NEUROBIOLOGY OF DISEASE (2014)
Pharmacological Inhibition of CXCR2 Chemokine Receptors Modulates Paraquat-Induced Intoxication in Rats
Kesiane M. Costa et al.
PLOS ONE (2014)
Abrogation of α-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats
Joao P. L. Daher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases-A mechanistic approach
Maria Teresa Baltazar et al.
TOXICOLOGY LETTERS (2014)
The neuroimmune-neuroplasticity interface and brain pathology
Egidio D'Angelo
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
IFN-γ differentially modulates memory-related processes under basal and chronic stressor conditions
Darcy Litteljohn et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Behavioral Characterization of A53T Mice Reveals Early and Late Stage Deficits Related to Parkinson's Disease
Katrina L. Paumier et al.
PLOS ONE (2013)
Non-Motor and Motor Features in LRRK2 Transgenic Mice
Zoe Bichler et al.
PLOS ONE (2013)
Paths from Pesticides to Parkinson's
Freya Kamel
SCIENCE (2013)
Vagotomy Attenuates Brain Cytokines and Sleep Induced by Peripherally Administered Tumor Necrosis Factor-alpha and Lipopolysaccharide in Mice
Mark R. Zielinski et al.
SLEEP (2013)
Neuron - glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage
GK Sheridan et al.
OPEN BIOLOGY (2013)
Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction
Marni N. Silverman et al.
NEUROIMMUNOMODULATION IN HEALTH AND DISEASE I (2012)
LRRK2 as a negative regulator of NFAT: implications for the pathogenesis of inflammatory bowel disease
Puja Vora et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2012)
Genetic modification of the association of paraquat and Parkinson's disease
Samuel M. Goldman et al.
MOVEMENT DISORDERS (2012)
Interferon-γ plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways
Emily N. Mangano et al.
NEUROBIOLOGY OF AGING (2012)
Genetic Dissection of Strain Dependent Paraquat-induced Neurodegeneration in the Substantia Nigra Pars Compacta
Yun Jiao et al.
PLOS ONE (2012)
LRRK2 and Human Disease: A Complicated Question or a Question of Complexes?
Patrick A. Lewis et al.
SCIENCE SIGNALING (2012)
Granulocyte macrophage-colony stimulating factor protects against substantia nigra dopaminergic cell loss in an environmental toxin model of Parkinson's disease
E. N. Mangano et al.
NEUROBIOLOGY OF DISEASE (2011)
Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice
B. Winner et al.
NEUROBIOLOGY OF DISEASE (2011)
Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3
Phillip M. Rappold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019S
Xianting Li et al.
JOURNAL OF NEUROSCIENCE (2010)
Dopamine Transporter Genetic Variants and Pesticides in Parkinson's Disease
Beate R. Ritz et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2009)
Cerebral Microglia Recruit Monocytes into the Brain in Response to Tumor Necrosis Factorα Signaling during Peripheral Organ Inflammation
Charlotte D'Mello et al.
JOURNAL OF NEUROSCIENCE (2009)
Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration
Emily N. Mangano et al.
NEUROBIOLOGY OF AGING (2009)
INTERFERON-γ DEFICIENCY MODIFIES THE MOTOR AND CO-MORBID BEHAVIORAL PATHOLOGY AND NEUROCHEMICAL CHANGES PROVOKED BY THE PESTICIDE PARAQUAT
D. Litteljohn et al.
NEUROSCIENCE (2009)
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease
L. N. Clark et al.
NEUROLOGY (2006)
Control of microglial neurotoxicity by the fractalkine receptor
Astrid E. Cardona et al.
NATURE NEUROSCIENCE (2006)
Non-motor symptoms of Parkinson's disease: diagnosis and management
KR Chaudhuri et al.
LANCET NEUROLOGY (2006)
LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs
S Lesage et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews
LJ Ozelius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The WAVE2 complex regulates actin cytoskeletal reorganization and CRAC-mediated calcium entry during T cell activation
JC Nolz et al.
CURRENT BIOLOGY (2006)
Regulation of actin assembly by SCAR/WAVE proteins
N Ibarra et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
Prevalence, etiology, and treatment of depression in Parkinson's disease
WA McDonald et al.
BIOLOGICAL PSYCHIATRY (2003)
Central monoamine and plasma corticosterone changes induced by a bacterial endotoxin: sensitization and cross-sensitization effects
S Hayley et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Synergistic effects of interleukin-1β, interleukin-6, and tumor necrosis factor-α:: Central monoamine, corticosterone, and behavioral variations
K Brebner et al.
NEUROPSYCHOPHARMACOLOGY (2000)
分享论文
